ATE220551T1 - Synergistische kombinationen von zidovudine, 1592u89 und 3tc - Google Patents

Synergistische kombinationen von zidovudine, 1592u89 und 3tc

Info

Publication number: ATE220551T1
Authority: AT; Austria
Prior art keywords: zidovudine; synergistic combinations; synergistic; combinations
Prior art date: 1995-03-30

Application number

AT96911953T

Other languages

German (de)

English (en)

Inventor

David Walter Barry

Clair Martha Heider St

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

1996-03-28

Publication date

2002-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE220551(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1996-03-28 Application filed by Wellcome Found filed Critical Wellcome Found

2002-08-15 Application granted granted Critical

2002-08-15 Publication of ATE220551T1 publication Critical patent/ATE220551T1/de

Links

239000011885 synergistic combination Substances 0.000 title 1
229960002555 zidovudine Drugs 0.000 title 1
HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Cephalosporin Compounds (AREA)
Medicinal Preparation (AREA)

AT96911953T 1995-03-30 1996-03-28 Synergistische kombinationen von zidovudine, 1592u89 und 3tc ATE220551T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en)	1995-03-30	1996-03-28	Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (1)

Publication Number	Publication Date
ATE220551T1 true ATE220551T1 (de)	2002-08-15

Family

ID=26306774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96911953T ATE220551T1 (de)	1995-03-30	1996-03-28	Synergistische kombinationen von zidovudine, 1592u89 und 3tc

Country Status (35)

Country	Link
US (1)	US6417191B1 (2)
EP (1)	EP0817637B1 (2)
JP (1)	JP2954357B2 (2)
KR (1)	KR100542536B1 (2)
CN (1)	CN1103593C (2)
AP (1)	AP652A (2)
AT (1)	ATE220551T1 (2)
AU (1)	AU715213B2 (2)
BR (3)	BRPI9607851B8 (2)
CA (1)	CA2216634C (2)
CZ (1)	CZ295940B6 (2)
DE (3)	DE69622386T2 (2)
DK (1)	DK0817637T3 (2)
EA (1)	EA000626B3 (2)
EE (1)	EE04047B1 (2)
ES (1)	ES2179193T3 (2)
FR (1)	FR05C0022I2 (2)
GE (1)	GEP20022647B (2)
HU (1)	HU224010B1 (2)
IL (1)	IL117727A (2)
LU (1)	LU91171I2 (2)
MX (1)	MX9707316A (2)
MY (1)	MY115461A (2)
NL (1)	NL300195I2 (2)
NO (2)	NO313787B1 (2)
NZ (1)	NZ306419A (2)
OA (1)	OA10616A (2)
PL (1)	PL187085B1 (2)
PT (1)	PT817637E (2)
RO (1)	RO117995B1 (2)
SI (1)	SI0817637T1 (2)
SK (1)	SK283825B6 (2)
TR (1)	TR199701074T1 (2)
UA (1)	UA60293C2 (2)
WO (1)	WO1996030025A1 (2)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997049411A1 (en)	1996-06-25	1997-12-31	Glaxo Group Limited	Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
BR9809127A (pt) *	1997-05-17	2000-08-01	Glaxo Group Ltd	Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
CA2374198A1 (en) *	1998-05-29	1999-12-02	Maki Arai	Combination therapy for treatment of fiv infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
AR040242A1 (es) *	2002-06-04	2005-03-23	Glaxo Group Ltd	Composiciones farmaceuticas
EA015145B1 (ru)	2003-01-14	2011-06-30	Джилид Сайэнс, Инк.	Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции
KR20050119652A (ko)	2003-03-24	2005-12-21	에프. 호프만-라 로슈 아게	역전사 효소 저해제로서의 벤질-피리다진온
DE602004030369D1 (de)	2003-10-24	2011-01-13	Immunaid Pty Ltd	Therapieverfahren
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
EP1940781A1 (en)	2005-10-19	2008-07-09	F.Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
MX2009005881A (es)	2006-12-13	2009-06-12	Hoffmann La Roche	Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
JP5467870B2 (ja) *	2007-02-09	2014-04-09	アルファファームピーティーワイリミテッド	異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
PL2435825T3 (pl)	2009-05-27	2015-12-31	Biotempus Ltd	Sposoby leczenia chorób
UA105556C2 (uk)	2010-01-27	2014-05-26	Віів Гелскер Компані	Комбінація сполук, що містить інгібітори віл інтегрази з іншими терапевтичними агентами
HK1220390A1 (zh)	2013-08-29	2017-05-05	Teva Pharmaceutical Industries Ltd.	包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
EP3129009A1 (en)	2014-04-08	2017-02-15	Teva Pharmaceutical Industries Ltd	Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN117164657A (zh)	2014-08-12	2023-12-05	莫纳什大学	定向淋巴的前药
EP3347340A4 (en)	2015-09-08	2019-01-23	Monash University	LYMPHENLEITUNGSPRODRUGS
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
WO2019046491A1 (en) *	2017-08-29	2019-03-07	Ariya Therapeutics, Inc.	LIPIDIC PRODRUGS DIRECTING TO THE LYMPHATIC SYSTEM
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
AU2021217172A1 (en)	2020-02-05	2022-09-22	Monash University	Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en)	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en) *	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
DE69206876T3 (de)	1991-05-16	2004-08-12	Glaxo Group Ltd., Greenford	Nukleosidanalogen enthaltende Antiviren-Zubereitungen
WO1993023021A2 (en) *	1992-05-13	1993-11-25	The Wellcome Foundation Limited	Therapeutic combinations
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
ATE230267T1 (de)	1996-06-25	2003-01-15	Glaxo Group Ltd	Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
WO1997049411A1 (en)	1996-06-25	1997-12-31	Glaxo Group Limited	Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
DE10226522A1 (de) *	2002-06-14	2003-12-24	Degussa	Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 EP EP96911953A patent/EP0817637B1/en not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en not_active Ceased
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active Expired - Lifetime
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown

Also Published As

Publication number	Publication date
CN1103593C (zh)	2003-03-26
JP2954357B2 (ja)	1999-09-27
NL300195I1 (nl)	2005-08-01
TR199701074T1 (xx)	1998-02-21
CA2216634C (en)	2004-07-20
CN1185110A (zh)	1998-06-17
AP9701089A0 (en)	1997-10-31
IL117727A0 (en)	1996-07-23
GEP20022647B (en)	2002-03-25
NZ306419A (en)	2000-01-28
PT817637E (pt)	2002-11-29
IL117727A (en)	1999-11-30
MX9707316A (es)	1997-11-29
SK283825B6 (sk)	2004-02-03
WO1996030025A1 (en)	1996-10-03
JPH10511682A (ja)	1998-11-10
HUP9801571A3 (en)	2001-04-28
EP0817637B1 (en)	2002-07-17
BRPI9612992B1 (pt)	2020-08-04
EP0817637A1 (en)	1998-01-14
DE69622386T2 (de)	2003-02-13
EA000626B3 (ru)	2016-04-29
NO313787B1 (no)	2002-12-02
FR05C0022I2 (2)	2005-10-21
SI0817637T1 (en)	2002-10-31
EA199700203A1 (ru)	1998-02-26
AU5497296A (en)	1996-10-16
OA10616A (en)	2001-03-15
AP652A (en)	1998-06-19
KR100542536B1 (ko)	2006-03-23
DE122005000029I1 (de)	2005-10-06
PL187085B1 (pl)	2004-05-31
BR9607851A (pt)	1998-07-21
BR9607851B1 (pt)	2009-01-13
DK0817637T3 (da)	2002-11-11
CZ295940B6 (cs)	2005-12-14
EA000626B1 (ru)	1999-12-29
UA60293C2 (uk)	2003-10-15
HU224010B1 (hu)	2005-04-28
ES2179193T3 (es)	2003-01-16
NO2005014I1 (no)	2005-06-06
FR05C0022I1 (2)	2005-06-10
NO2005014I2 (no)	2008-02-11
MY115461A (en)	2003-06-30
LU91171I9 (2)	2018-12-28
LU91171I2 (fr)	2005-07-04
NO974510D0 (no)	1997-09-29
BRPI9607851B8 (pt)	2019-11-05
KR19980703420A (ko)	1998-11-05
AU715213B2 (en)	2000-01-20
CA2216634A1 (en)	1996-10-03
CZ309097A3 (cs)	1998-05-13
RO117995B1 (ro)	2002-12-30
PL322532A1 (en)	1998-02-02
US6417191B1 (en)	2002-07-09
HK1009401A1 (en)	1999-09-10
SK129597A3 (en)	1998-07-08
DE122005000029I2 (de)	2006-04-27
HUP9801571A2 (hu)	1999-01-28
NO974510L (no)	1997-09-29
EE04047B1 (et)	2003-06-16
EE9700240A (et)	1998-04-15
NL300195I2 (nl)	2005-11-01
DE69622386D1 (de)	2002-08-22

Publication	Publication Date	Title
DE69622386D1 (de)	2002-08-22	Synergistische kombinationen von zidovudine, 1592u89 und 3tc
DE69415157D1 (de)	1999-01-21	Elektrochirurgischer prozessor und anwendung
DE69627513D1 (de)	2003-05-22	Kochgerät und dessen betriebsverfahren
BR9702553A (pt)	1998-09-29	Composição cosmética e utilização
DE69608973D1 (de)	2000-08-03	Schalter und diesen enthaltende Schaltungsanordnung
DE69842004D1 (de)	2010-12-30	Substituierte 2-aminoacetamide und anwendung davon
BR9601693A (pt)	1998-03-31	Composição e seus usos
DE69600316D1 (de)	1998-07-02	Haarkosmetische Zusammensetzung
DE69629987D1 (de)	2003-10-23	Funktelefone und Betriebsverfahren
BR9609831A (pt)	1999-03-09	Composições cosméticas e/ou farmacêuticas antipruríticas
DE69634489D1 (de)	2005-04-21	Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
ATE257708T1 (de)	2004-01-15	Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
BR9506389B1 (pt)	2009-08-11	composto de silìcio, e, composição dietética, cosmética e terapêutica.
FI972988L (fi)	1997-09-11	Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
DE69624042D1 (de)	2002-11-07	TiO2 dotiertes, Ta2O5 enthaltendes dielektrisches Material und dieses enthaltende Bauteile
FI952738L (fi)	1995-07-31	Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
KR960030598U (ko)	1996-10-22	이,미용원용가습장치
ATE228575T1 (de)	2002-12-15	Wirkstoffkombinationen
BR9611178A (pt)	1999-03-30	Composiç o em creme
FI972965L (fi)	1997-07-11	Uusia peptidejä, niiden valmistus ja käyttö
DE59607418D1 (de)	2001-09-06	Haarbehandlungsmittel
FI963720A0 (fi)	1996-09-19	N-aryyli- ja N-alkyylisulfonyyliaminaalit tuholaisten torjunta-aineina
FR2761061B1 (fr)	1999-04-23	Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
KR960033565U (ko)	1996-11-19	지압 및 쑥뜸 겸용 지압구
PT101949A (pt)	1997-06-30	Boneco com elevacao simultania de bracos, pernas e abertura de olhos